JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 21, 2005; DOI: 10.1124/jpet.105.097303


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.097303v1
316/2/869    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braverman, A. S
Right arrow Articles by Ruggieri, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braverman, A. S
Right arrow Articles by Ruggieri, M. R.


Received for publication October 18, 2005.
Revised October 20, 2005.
Accepted for publication October 20, 2005.

M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. I. Normal Rat Bladder

Alan S Braverman 1, Amit Tibb 1, Michael R. Ruggieri 1*

1 Temple University School of Medicine

* Address correspondence to: E-mail: rugg1{at}msn.com

Abstract

The signal transduction mechanisms activated by muscarinic receptor subtypes mediating rat urinary bladder contraction are incompletely understood. Normal rat bladder contractions are mediated by the M3 muscarinic receptor subtype, however, the M2 receptor subtype has a more dominant role in contractions of the hypertrophied bladder. Normal bladder muscle strips were exposed to inhibitors of enzymes thought to be involved in signal transduction in- vitro followed by a single cumulative concentration response curve to the muscarinic receptor agonist carbachol. The outcome measures were the maximal contraction, the potency of carbachol, and the affinity of the M3 selective antimuscarinic agent darifenacin for inhibition of contraction. Inhibition of PI-PLC with ET-18-OCH3 reduces carbachol potency and reduces darifenacin affinity, while inhibition of PC-PLC with D609 attenuates the carbachol maximal contraction. Inhibition of rho kinase with Y-27632 reduces carbachol potency and increases darifenacin affinity. Inhibition of rho kinase, PKA and PKG with HA-1077 reduces the carbachol maximal contraction, carbachol potency and darifenacin affinity. Inhibition of PKC with chelerythrine increases darifenacin affinity while inhibition of rho kinase, PKA, PKG, and PKC with H7 reduces the carbachol maximum, carbachol potency while increasing darifenacin affinity. Inhibition of rho kinase, PKA and PKG with H89 reduces carbachol maximum and carbachol potency. Both the M2 and the M3 receptor subtype are involved in normal rat bladder contractions. The M3 subtype appears to mediate contraction by activation of PI-PLC, PC-PLC, and PKA, while the M2 signal transduction cascade may include activation of rho kinase, PKC, and an additional contractile signal transduction mechanism independent of rho kinase or PKC.


Key words: Rho Kinase, carbachol, phospholipases, protein kinases, signal transduction, urinary bladder


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
E. P. Frazier, A. S. Braverman, S. L. M. Peters, M. C. Michel, and M. R. Ruggieri Sr.
Does Phospholipase C Mediate Muscarinic Receptor-Induced Rat Urinary Bladder Contraction?
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 998 - 1002.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. S. Braverman, L. R. Doumanian, and M. R. Ruggieri Sr
M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. II. Denervated Rat Bladder
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 875 - 880.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.